Rotate Your Device

This site doesn't support landscape mode. Please rotate your phone to portrait.

Tucuvi

Tucuvi

Tucuvi is a global AI Care Management platform for healthcare systems, designed to actively deliver care at scale. Tucuvi's platform automates and orchestrates high-volume clinical and care coordination workflows end to end, helping healthcare organizations move beyond isolated automation to truly proactive care management. It integrates autonomous AI agents, including LOLA, with workflow logic, escalation, documentation, and seamless integration into existing health system infrastructure, supporting patient phone interactions and escalating to clinical teams when needed. Built for trust and clinical reality, Tucuvi is the first Class IIb Software as a Medical Device (SaMD) approved AI platform in Europe for its Voice AI agent and patient management platform. We support 50+ care workflows across care transitions, chronic disease management, screenings, scheduling, and medication management, delivering measurable impact across 60+ healthcare organizations, including up to 80% automation…

New York City, United States11-50 employeesFounded 2019

Overview

Tucuvi is a health technology company unlocking efficient and high-quality healthcare at scale with a CE-marked platform for Phone Consultation Automation. We develop safe and clinically validated Conversational AI for any care pathway, enabling clinical teams to augment their capacities, improve processes’ efficiency and efficacy, and achieve better patient outcomes and satisfaction through continuous and personalized care.

Tech Stack

Iphone / mobile compatibleViewport metaDomain not resolvingSpfSsl by defaultApple mobile web clips iconGoogle tag managerHstsGoogle font apiGoogle analyticsAIAmazon AWSGmailGoogle AppsGoogle Tag ManagerMobile FriendlyRemoteRenderSegment.ioSendInBlueVarnishWebflowYouTubeReCAPTCHA

Funding History

Pre Seed Round

$177K

May 2020

Pre Seed Round

$119K

Apr 2021

Grant

$360K

Mar 2022

NEOTEC

Pre Seed Round

$821K

Aug 2022

Shilling

Grant

$2.4M

Oct 2022

European Innovation Council